Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

dolasetron

dolasetron
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Anzemet SOLUTION, INTRAVENOUS 20 mg/mL    
Anzemet TABLET, ORAL 50 mg, 100 mg      
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

dolasetron (Anzemet)

  • 12.5 mg and 25 mg IV  x 1 dose
  • 12.5 mg and 25 mg IV q 6 hours
  • 12.5 mg and 25 mg IV q 8 hours
  • 12.5 mg and 25 mg IV q 6-8 hours
  • 12.5 mg and 25 mg IV q 12 hours

ondansetron (Zofran)

  • 4 mg IV x 1 dose
  • 4 mg IV q 6 hours
  • 4 mg IV q 6 hours
  • 4 mg IV q 6 hours
  • 4 mg IV q 12 hours

Anzemet injection is classified as non-formulary, not stocked for safety reasons. Interchange according to the formulary program (see link). Anzemet injection must be reviewed again by the P&T Committee before use at HH.

Reviewed: January 25, 2011 (dolasetron injection)

Last updated: Dec. 14, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved